Smucny J J, Becker L A, Glazier R H, McIsaac W
Department of Family Medicine, State University of New York Health Science Center, Syracuse, USA.
J Fam Pract. 1998 Dec;47(6):453-60.
Most clinicians prescribe antibiotics for acute bronchitis in spite of recommendations against this practice. Because the results of individual clinical trials have been mixed, we conducted a meta-analysis to determine whether antibiotics are effective treatment for acute bronchitis.
We conducted a comprehensive search to identify all trials in which patients who had a diagnosis of acute bronchitis were randomly assigned to treatment with an antibiotic or placebo. Patient-oriented outcomes of importance that were reported in at least 3 studies were quantitatively summarized.
Nine studies met the inclusion criteria, but not all trials provided data for each outcome. Patients given antibiotics were less likely to have a cough (relative risk [RR] = 0.69; 95% confidence interval [CI], 0.49 -0.98) and be considered unimproved (RR = 0.51; 95% CI, 0.30-0.88) at a follow-up visit; but they were not less likely to have a productive cough (RR = 0.79; 95% CI, 0.60-1.03), activity limitations (RR = 0.59; 95% CI, 0.24-1.44), or feel ill (RR = 0.70; 95% CI, 0.31-1.58). Antibiotic-treated patients had a slightly shorter duration of productive cough (weighted mean difference [WMD] = -0.56 days; 95% CI, -1.09 to -0.04), but not of overall cough (WMD = -0.94; 95% CI, -2.08 to 0.21) or activity limitations (WMD = -0.49; 95% CI, -1.07 to 0.10). Patients treated with antibiotics did not report significantly more adverse effects (RR = 1.47; 95% CI, 0.82-2.65).
Antibiotics may be modestly effective for a minority of patients with acute bronchitis. It is not clear which patient subgroups might benefit, and the failure of some studies to report negative findings may have resulted in overestimates of the benefits of antibiotics. Antibiotics are not necessary for every patient with acute bronchitis.
尽管有不建议使用抗生素治疗急性支气管炎的相关建议,但大多数临床医生仍会开具抗生素。由于个别临床试验结果不一,我们进行了一项荟萃分析,以确定抗生素对急性支气管炎是否为有效治疗方法。
我们进行了全面检索,以确定所有将诊断为急性支气管炎的患者随机分配接受抗生素或安慰剂治疗的试验。对至少3项研究所报告的重要的以患者为导向的结局进行了定量总结。
9项研究符合纳入标准,但并非所有试验都提供了每项结局的数据。接受抗生素治疗的患者在随访时咳嗽的可能性较小(相对危险度[RR]=0.69;95%置信区间[CI],0.49-0.98),且被认为病情未改善的可能性较小(RR=0.51;95%CI,0.30-0.88);但他们咳痰性咳嗽(RR=0.79;95%CI,0.60-1.03)、活动受限(RR=0.59;95%CI,0.24-1.44)或感觉不适(RR=0.70;95%CI,0.31-1.58)的可能性并不小。接受抗生素治疗的患者咳痰性咳嗽的持续时间略短(加权均数差[WMD]=-0.56天;95%CI,-1.09至-0.04),但总体咳嗽(WMD=-0.94;95%CI,-2.08至0.21)或活动受限(WMD=-0.49;95%CI,-1.07至0.10)的持续时间并未缩短。接受抗生素治疗的患者报告的不良反应并未显著更多(RR=1.47;95%CI,0.82-2.65)。
抗生素可能对少数急性支气管炎患者有一定疗效。尚不清楚哪些患者亚组可能受益,而且一些研究未报告阴性结果可能导致高估了抗生素的益处。并非每位急性支气管炎患者都需要使用抗生素。